Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
SCNI Scinai Immunotherapeutics
- 2.514
- +0.094+3.86%
Close Apr 25 16:00 ET
2.35MMarket Cap1.05P/E (TTM)
2.690High2.514Low1.22KVolume2.690Open2.420Pre Close3.11KTurnover0.22%Turnover RatioLossP/E (Static)933.68KShares8.92052wk High0.54P/B1.42MFloat Cap1.90052wk Low--Dividend TTM565.96KShs Float6199.990Historical High--Div YieldTTM7.29%Amplitude1.900Historical Low2.552Avg Price1Lot Size
About Scinai Immunotherapeutics Company
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Company Profile
SymbolSCNI
Company NameScinai Immunotherapeutics
Listing DateMay 12, 2015
Founded2003
CEOMr. Amir Reichman
MarketNASDAQ
Employees31
Securities TypeDR
ADS Ratio1.0 : 4000.0
Fiscal Year Ends12-31
AddressJerusalem BioPark,Hadassah Ein Kerem Campus,2nd Floor
CityJerusalem
ProvinceJerusalem
CountryIsrael
Zip Code74036
Phone972-302-930-2529
Websitehttp://www.scinai.com
Company Executives
- Name
- Position
- Salary
- Amir Reichman
- Chief Executive Officer and Director
- 927.00K
- Uri Ben-Or
- Chief Financial Officer
- 174.00K
- Elad Mark
- Chief Operating Officer
- 265.00K
- Dalit Weinstein Fischer
- Chief Technology Officer
- 232.00K
- Mark Germain
- Chairman of the Board
- --
- Samuel J. Moed
- Director
- --
- Jay Green
- Independent Director
- --
- Avner Rotman
- Independent Director
- --
- Adi Raviv
- Independent Director
- --
- Dr. Yael Margolin, M.Sc.,PhD
- Independent Director
- --
- Dr. Morris Laster, M.D.
- Independent Director
- --
- Dr. Tamar Ben Yedidia
- Chief Scientist
- 297.00K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
